Journal of Inorganic Materials, Volume. 36, Issue 12, 1305(2021)

Potassium Ferrate-loaded Porphyrin-based (VI) Metal-organic Frameworks for Combined Photodymanic and Chemodynamic Tumor Therapy

Yuwei WANG*... Jiajie CHEN, Zhengfang TIAN, Min ZHU and Yufang ZHU |Show fewer author(s)

Metal-organic frameworks (MOFs) are widely used in biomedicine due to their porous structure, high specific surface area, abundant functional groups with metal active sites, good biocompatibility, and suitable degradability. In this study, a multifunctional composite nanoparticle (Fe(VI)@PCN@BSA) was prepared for combined photodynamic and chemodynamic therapy of tumors, which was constructed by loading potassium ferrate (K2FeO4, Fe(VI)) in porphyrin-based MOFs (PCN-224) and following a surface coating with biocompatible bovine serum albumin (BSA). The results showed that the particle sizes of PCN-224 and Fe(VI)@PCN@BSA nanoparticles were about 90 nm and 100 nm, respectively. Interestingly, Fe(VI)@PCN@BSA nanoparticles could catalyze H2O2 to produce ?OH under a simulating tumor environmental condition. Meanwhile, they catalyzed to decompose H2O2 to produce O2, and thereby increased the production of singlet oxygen (1O2) under 660 nm laser irradiation, which enhanced the photodynamic effect. More importantly, in vitro evaluation indicated that Fe(VI)@PCN@BSA nanoparticles were biocompatible, and exhibited enhanced photodynamic and chemodynamic combined therapeutic efficacy against tumor cells. Hence, Fe(VI)@PCN@BSA nanoparticles have a great potential application in tumor therapy.

Tools

Get Citation

Copy Citation Text

Yuwei WANG, Jiajie CHEN, Zhengfang TIAN, Min ZHU, Yufang ZHU. Potassium Ferrate-loaded Porphyrin-based (VI) Metal-organic Frameworks for Combined Photodymanic and Chemodynamic Tumor Therapy[J]. Journal of Inorganic Materials, 2021, 36(12): 1305

Download Citation

EndNote(RIS)BibTexPlain Text
Save article for my favorites
Paper Information

Category: EDITORIAL

Received: Mar. 12, 2021

Accepted: --

Published Online: Sep. 16, 2022

The Author Email: WANG Yuwei (676627664@qq.com)

DOI:10.15541/jim20210157

Topics